Fumaric Acid

Fumaric Acid

SCHEMBL9050663

O=C(C1CCc2[nH]cnc2C1)N1CCOc2ccccc21.O=C(O)/C=C/C(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.41
HSD11B1 P28845 1/20 0.39
SLC22A12 Q96S37 4/20 0.38
MAPT P10636 4/20 0.37
POLB P06746 2/20 0.37
USP30 Q70CQ3 2/20 0.37
TP53 P04637 1/20 0.37
LMNA P02545 2/20 0.37
PDK1 Q15118 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9050668 0.93 HTR3A (0.42) NOTUMHSD11B1SLC22A12MAPTPOLB
Fumaric Acid SCHEMBL9051209 0.85 TSHR (0.52) MAPTPOLBLMNA
Fumaric Acid SCHEMBL9052770 0.83 POLB (0.52) HSD11B1MAPTPOLBLMNA
Fumaric Acid SCHEMBL9074189 0.79 HTR3A (0.44) NOTUMLMNA
SCHEMBL1023583 0.78 TSHR (0.59) NOTUMMAPTPOLBLMNA
SCHEMBL1023584 0.78 TSHR (0.59) NOTUMMAPTPOLBLMNA
Hydrochloric Acid SCHEMBL9050997 0.77 TSHR (0.57) NOTUMMAPTPOLBLMNA
Hydrochloric Acid SCHEMBL1023299 0.77 TSHR (0.57) NOTUMMAPTPOLBLMNA
SCHEMBL9050664 0.77 IDH1 (0.36) HSD11B1MAPT
Fumaric Acid SCHEMBL9051223 0.77 TSHR (0.52) MAPTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0381422-B1 Tetrahydrobenzimidazole derivatives YAMANOUCHI PHARMA CO LTD (JP) 1996-10-23 EP disclosed
US-5496942-A 5-HT3-RECEPTOR ANTAGONISTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
US-5344927-A 5-HT3 antagonist YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-09-06 US disclosed
EP-0381422-A1 Tetrahydrobenzimidazole derivatives YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1990-08-08 EP disclosed